Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
Clinical trial NCT03188991 · COMPLETED
Trial details
- NCT number
- NCT03188991
- Sponsor
- NanOlogy, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2020-06-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.